{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:09:27Z","timestamp":1790647767360,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.tips.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T02:34:20Z","timestamp":1504233260000},"page":"956-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Early and Late CNS Inflammation in Alzheimer\u2019s Disease: Two Extremes of a Continuum?"],"prefix":"10.1016","volume":"38","author":[{"given":"A. Claudio","family":"Cuello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2017.07.005_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt118","article-title":"Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer\u2019s disease","volume":"4","author":"Eikelenboom","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tips.2017.07.005_bib0010","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg Zeitschrift Psych"},{"key":"10.1016\/j.tips.2017.07.005_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000211873","article-title":"Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelm\u00e4ssige Ver\u00e4nderung der Hirnrinde bei seniler Demenz","volume":"22","author":"Fischer","year":"1907","journal-title":"Monatsschr Psychiat Neurol."},{"key":"10.1016\/j.tips.2017.07.005_bib0020","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/awn256","article-title":"Oskar Fischer and the study of dementia","volume":"132","author":"Goedert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.tips.2017.07.005_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","article-title":"Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study","volume":"57","author":"Eikelenboom","year":"1982","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2017.07.005_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00689592","article-title":"Expression of the histocompatibility glycoprotein HLA-DR in neurological disease","volume":"76","author":"McGeer","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2017.07.005_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","article-title":"Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR","volume":"79","author":"McGeer","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2017.07.005_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000116224","article-title":"Acute-phase proteins in Alzheimer\u2019s disease","volume":"28","author":"Giometto","year":"1988","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.tips.2017.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(90)91101-F","article-title":"Anti-inflammatory drugs and Alzheimer disease","volume":"335","author":"McGeer","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2017.07.005_bib0050","first-page":"295","article-title":"Inflammatory response in Alzheimer\u2019s disease","volume":"174","author":"Tohoku","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2017.07.005_bib0055","series-title":"Lectures on the Comparative Pathology of Inflammation Delivered at The Pasteur Institute in 1891","author":"Metchnikoff","year":"1893"},{"key":"10.1016\/j.tips.2017.07.005_bib0060","first-page":"58","article-title":"Immunity to homologous grafted skin. III. The fate of skin homographs transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.tips.2017.07.005_bib0065","first-page":"419","article-title":"Unique aspects of central nervous system immunology","volume":"3","author":"Neuwelt","year":"1978","journal-title":"Neurosurgery"},{"key":"10.1016\/j.tips.2017.07.005_bib0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000354228","article-title":"Neuroinflammatory phenotypes and their roles in Alzheimenr\u2019s disease","volume":"13","author":"Wilcock","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.tips.2017.07.005_bib0075","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2009.00290.x","article-title":"Resolvins and protectins: mediating solutions to inflammation","volume":"158","author":"Kohli","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2017.07.005_bib0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2017.07.005_bib0085","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2017.07.005_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1742-2094-8-171","article-title":"Neuroinflammation in Alzheimer\u2019s disease wanes with age","volume":"8","author":"Hoozemans","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2017.07.005_bib0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2017.07.005_bib0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.09.061","article-title":"Neuroinflammation in Alzheimer\u2019s disease; a source of heterogeneity and target for personalized therapy","volume":"302","author":"Latta","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2017.07.005_bib0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down\u2019s syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2017.07.005_bib0110","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tips.2017.07.005_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-11-25","article-title":"Modulation of inflammation in transgenic models of Alzheimer\u2019s disease","volume":"11","author":"Birch","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2017.07.005_bib0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/156720511795256062","article-title":"Inflammatory risk factors and pathologies associated with Alzheimer\u2019s disease","volume":"8","author":"Sastre","year":"2011","journal-title":"J. Curr. Alzheimer Res."},{"key":"10.1016\/j.tips.2017.07.005_bib0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13311-014-0316-8","article-title":"The evolving biology of microglia in Alzheimer\u2019s disease","volume":"12","author":"Malm","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2017.07.005_bib0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease \u2013 a double-edged sword","volume":"35","author":"Wiss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2017.07.005_bib0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/87839","article-title":"Inflammation and Alzheimer disease: the good, the bad, and the ugly","volume":"7","author":"Weninger","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2017.07.005_bib0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2017.07.005_bib0145","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2017.07.005_bib0150","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2017.07.005_bib0155","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1002\/cne.23463","article-title":"Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration","volume":"521","author":"Lampron","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2017.07.005_bib0160","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1073\/pnas.1215165110","article-title":"Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer\u2019s disease-related pathology","volume":"110","author":"Michaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2017.07.005_bib0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2017.07.005_bib0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2017.07.005_bib0175","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jalz.2014.10.013","article-title":"The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer\u2019s Dementia","volume":"11","author":"Roussos","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2017.07.005_bib0180","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMcibr1503954","article-title":"TREM 2 and risk of Alzheimer\u2019s disease: friend or foe?","volume":"372","author":"Tanzi","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2017.07.005_bib0185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","article-title":"Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease","volume":"37","author":"Jay","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2017.07.005_bib0190","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2017.07.005_bib0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer\u2019s disease: a systematic review","volume":"327","author":"Szekely","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2017.07.005_bib0200","first-page":"248","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer\u2019s disease: systematic review and meta-analysis of observational studies","volume":"24","author":"Etminan","year":"2002","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.tips.2017.07.005_bib0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/epirev\/mxf001","article-title":"Pharmacologic agents associated with a preventive effect on Alzheimer\u2019s disease: a review of the epidemiologic evidence","volume":"24","author":"Veld","year":"2002","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.tips.2017.07.005_bib0210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tips.2017.07.005_bib0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40266-015-0239-z","article-title":"Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis of treatment effect","volume":"32","author":"Miguel-\u00c1lvarez","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.tips.2017.07.005_bib0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1533317514542644","article-title":"Role of traditional nonsteroidal anti-inflammatory drugs in Alzheimer\u2019s disease: a meta-analysis of randomized clinical trials","volume":"30","author":"Gupta","year":"2015","journal-title":"Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.tips.2017.07.005_bib0225","first-page":"CD006378","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2017.07.005_bib0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial and its Follow-up Study","volume":"11","author":"ADAPT-FS Research Group","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2017.07.005_bib0235","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","article-title":"ADAPT: extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial","volume":"7","author":"Breitner","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2017.07.005_bib0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Update on hypothetical model of Alzheimer\u2019s disease biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tips.2017.07.005_bib0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000283480","article-title":"Neuroinflammation \u2013 an early event in both the history and pathogenesis of Alzheimer\u2019s disease","volume":"7","author":"Eikelenboom","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.tips.2017.07.005_bib0250","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2006.08.014","article-title":"Inflammatory changes parallel the early stages of Alzheimer disease","volume":"28","author":"Parachikova","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2017.07.005_bib0255","first-page":"21","article-title":"Imaging of neuroinflammation in dementia: a review","volume":"87","author":"Stefaniak","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tips.2017.07.005_bib0260","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/brain\/awv404","article-title":"Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease","volume":"139","author":"Rodriguez-Vieitez","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tips.2017.07.005_bib0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in Down syndrome and the development of Alzheimer\u2019s disease neuropathology","volume":"13","author":"Head","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tips.2017.07.005_bib0270","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer\u2019s disease: common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2017.07.005_bib0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000063649","article-title":"Chemokines and pro-inflammatory cytokines in Down\u2019s syndrome: an early marker for Alzheimer-type dementia?","volume":"71","author":"Carta","year":"2002","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.tips.2017.07.005_bib0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/039463200501800117","article-title":"Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer\u2019s type","volume":"18","author":"Licastro","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.tips.2017.07.005_bib0285","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jalz.2016.05.001","article-title":"An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: relation to cognitive decline and longitudinal evaluation","volume":"12","author":"Iulita","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2017.07.005_bib0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-2-23","article-title":"Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer\u2019s disease mice","volume":"2","author":"Janelsins","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2017.07.005_bib0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-2-22","article-title":"Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP [V717I] transgenic mice","volume":"2","author":"Heneka","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2017.07.005_bib0300","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/NEN.0b013e3181c22569","article-title":"Increased matrix metalloproteinase 9 activity in mild cognitive impairment","volume":"68","author":"Bruno","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tips.2017.07.005_bib0305","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.neurobiolaging.2011.01.007","article-title":"Intracellular A\u03b2-oligomers and early inflammation in a model of Alzheimer\u2019s disease","volume":"33","author":"Ferretti","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2017.07.005_bib0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000333339","article-title":"Preplaque (\u2018preclinical\u2019) A\u03b2-induced inflammation and nerve growth factor deregulation in transgenic models of Alzheimer\u2019s disease-like amyloid pathology","volume":"10","author":"Cuello","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.tips.2017.07.005_bib0315","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","article-title":"Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer\u2019s disease","volume":"35","author":"Hanzel","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tips.2017.07.005_bib0320","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer\u2019s disease","volume":"20","author":"Lim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2017.07.005_bib0325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer\u2019s disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"McAlpine","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2017.07.005_bib0330","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/glia.20338","article-title":"Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice","volume":"53","author":"Seabrook","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.tips.2017.07.005_bib0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-9-62","article-title":"Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology","volume":"9","author":"Ferretti","year":"2012","journal-title":"J. Neuroinflammation"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471730144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561471730144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T08:01:28Z","timestamp":1530086488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561471730144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S016561471730144X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2017.07.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and Late CNS Inflammation in Alzheimer\u2019s Disease: Two Extremes of a Continuum?","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}